Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report

Tugcu M., Kasapoglu U., Boynuegri B., Can O., Gokce A. M. , Ruhi C. , ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.47, sa.5, ss.1528-1530, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background. New-onset diabetes after transplantation (NODAT) is a common metabolic complication. Most conventional immunosuppressive medications, especially steroids and tacrolimus, are responsible for its development. NODAT may rarely be associated with severe, life-threating complications in kidney transplantation recipients.